Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Spirit Airlines emerges from chapter 11
We advised Spirit in connection with its chapter 11 cases
Primo Brands $1.5 billion debut secondary offering
The shares are listed on the New York Stock Exchange
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Axon Enterprise $1.75 billion senior notes offering
The high-yield notes are due 2030 and 2033
Verisk $700 million senior notes offering
We advised Verisk on the SEC-registered notes
Endo divestiture of International Pharmaceuticals business
We are advising Endo on the transaction
Strategy $21 billion perpetual strike preferred stock at-the-market offering
The perpetual strike preferred stock is listed on the Nasdaq Global Select Market
Bread Financial Holdings $400 million subordinated notes offering
We advised Bread Financial on its subordinated debt offering
CSX $600 million senior notes offering
We advised CSX on the investment-grade debt offering